Attention Deficit Hyperactivity Disorder (ADHD) Quiz

Check your symptoms and
find possible causes with AI for free

Worried about your symptoms?

Start the test with our free AI Symptom Checker.

This will help us personalize your assessment.

Shiba

By starting the symptom checker, you agree to the Privacy Policy and Terms of Use

Forgetfulness

Disorganized speech

Increased irritability

Always fidgeting

Memory issues

Easily distracted

Trouble concentrating

Acting without thinking

Difficulty focusing

Unable to sit still

Disorganized thinking

Feeling uneasy and anxious

Not seeing your symptoms? No worries!

What is Attention Deficit Hyperactivity Disorder (ADHD)?

Attention deficit hyperactivity disorder (ADHD) is a condition that is characterized by attention difficulty, hyperactivity, and inability to control one's behavior (impulsiveness). It often starts in childhood and can cause a child to struggle in school, at home, or in social relationships. It is more common in male children. The causes of ADHD remain unclear but risk factors include genetic factors, tobacco use during pregnancy, premature delivery, and low birth weight.

Typical Symptoms of Attention Deficit Hyperactivity Disorder (ADHD)

Diagnostic Questions for Attention Deficit Hyperactivity Disorder (ADHD)

Your doctor may ask these questions to check for this disease:

  • Have you been feeling unusually energetic lately?
  • Do you have difficulty concentrating?
  • Have you noticed or been told that you are acting strangely or differently?
  • Do you feel stressed or unhappy about going to work or school?
  • Recently, are you more confused than before?

Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

There is no cure for ADHD, but various treatments such as medications, behavior therapy, counseling, and education services can help improve the child's symptoms and behavior.

Reviewed By:

Benjamin Kummer, MD

Benjamin Kummer, MD (Neurology)

Dr Kummer is Assistant Professor of Neurology at the Icahn School of Medicine at Mount Sinai (ISMMS), with joint appointment in Digital and Technology Partners (DTP) at the Mount Sinai Health System (MSHS) as Director of Clinical Informatics in Neurology. As a triple-board certified practicing stroke neurologist and informaticist, he has successfully improved clinical operations at the point of care by acting as a central liaison between clinical neurology faculty and DTP teams to implement targeted EHR configuration changes and workflows, as well as providing subject matter expertise on health information technology projects across MSHS. | Dr Kummer also has several years’ experience building and implementing several informatics tools, presenting scientific posters, and generating a body of peer-reviewed work in “clinical neuro-informatics” – i.e., the intersection of clinical neurology, digital health, and informatics – much of which is centered on digital/tele-health, artificial intelligence, and machine learning. He has spearheaded the Clinical Neuro-Informatics Center in the Department of Neurology at ISMMS, a new research institute that seeks to establish the field of clinical neuro-informatics and disseminate knowledge to the neurological community on the effects and benefits of clinical informatics tools at the point of care.

Shohei Harase, MD

Shohei Harase, MD (Neurology)

Dr. Harase spent his junior and senior high school years in Finland and the U.S. After graduating from the University of Washington (Bachelor of Science, Molecular and Cellular Biology), he worked for Apple Japan Inc. before entering the University of the Ryukyus School of Medicine. He completed his residency at Okinawa Prefectural Chubu Hospital, where he received the Best Resident Award in 2016 and 2017. In 2021, he joined the Department of Cerebrovascular Medicine at the National Cerebral and Cardiovascular Center, specializing in hyperacute stroke.

From our team of 50+ doctors

Content updated on Oct 18, 2024

Following the Medical Content Editorial Policy

Was this page helpful?

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

Think you might have
Attention Deficit Hyperactivity Disorder (ADHD)?

Try a symptom check test

How Ubie Can Help You

With a free 3-min quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.

This questionnaire is customized to your situation and symptoms, including the following personal information:

  • Biological Sex - helps us provide relevant suggestions for male vs. female conditions.

  • Age - adjusts our guidance based on any age-related health factors.

  • History - considers past illnesses, surgeries, family history, and lifestyle choices.

Your symptoms

Input your symptoms

Our AI

Our AI checks your symptoms

Your report

You get your personalized report

Your personal report will tell you

✔  When to see a doctor

✔︎  What causes your symptoms

✔︎  Treatment information etc.

People with similar symptoms also use Ubie's symptom checker to find possible causes

See full list

Symptoms Related to Attention Deficit Hyperactivity Disorder (ADHD)

Diseases Related to Attention Deficit Hyperactivity Disorder (ADHD)

FAQs

Q.

Can't Focus at Work? The Connection Between Sleep and ADHD

A.

Trouble focusing at work is often driven by poor sleep, ADHD, or both, and they commonly feed into each other; sleep loss can mimic ADHD symptoms, while ADHD can disrupt sleep, so improving sleep can significantly sharpen attention. There are several factors to consider, including which sleep disorders to rule out, how to tell if longstanding patterns point to ADHD, and practical steps for routines, screening, treatment, and when to see a doctor. See below for the complete guidance and next steps that could affect your healthcare decisions.

References:

* Soria, S., & Bär, S. (2019). Sleep problems in adults with ADHD: a systematic review and meta-analysis. *Journal of Psychiatric Research*, *114*, 148-154.

* Wajs, E., & Svirsky, M. J. (2019). Sleep in adults with ADHD: a review of current literature and treatment implications. *Current Psychiatry Reports*, *21*(12), 126.

* Weissenberger, S., Zöller, D., Romanos, M., & Jacob, C. P. (2018). The impact of sleep deprivation on attention and executive functions in adults with and without ADHD. *Journal of Attention Disorders*, *22*(8), 754-766.

* Hvolby, A., & Bäckström, A. (2021). The Role of Sleep in Attention Deficit Hyperactivity Disorder (ADHD) across the Lifespan. *Brain Sciences*, *11*(6), 724.

* Gunn, S., & Rosén, F. K. (2020). Impact of sleep problems on quality of life in adults with ADHD: an observational study. *Sleep Medicine*, *70*, 17-23.

See more on Doctor's Note

Q.

Still struggling? The Bipolar-ADHD comorbidity reality and the new clinical steps to relief.

A.

Bipolar and ADHD often co-occur and are easily mistaken for each other; the modern approach is to stabilize bipolar mood first, then reassess and treat ongoing ADHD with cautious medication, therapy, routines, and sleep protection. There are several factors to consider, including how to avoid stimulant-triggered mania, what habits matter most, red flags that need urgent care, and the exact questions to ask your doctor; see the complete guidance below.

References:

* Joshi G, et al. Attention-deficit/hyperactivity disorder and bipolar disorder in children and adolescents: comorbidity, diagnosis, and treatment challenges. J Affect Disord. 2021 May 1;286:201-210. doi: 10.1016/j.jad.2021.03.003. Epub 2021 Mar 5.

* Faraone SV, et al. Attention-deficit/hyperactivity disorder and bipolar disorder: distinct but often co-occurring. J Affect Disord. 2021 Sep 1;292:433-439. doi: 10.1016/j.jad.2021.05.093. Epub 2021 Jun 2.

* Young S, et al. Management of individuals with co-occurring attention-deficit/hyperactivity disorder and bipolar disorder: a narrative review. J Clin Psychiatry. 2022 May 31;83(3):21nr14227. doi: 10.4088/JCP.21nr14227.

* Caci H, et al. Comorbid Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Diagnostic Challenges and Therapeutic Management. CNS Drugs. 2019 Jun;33(6):537-550. doi: 10.1007/s40263-019-00627-0.

* Perugi G, et al. Current perspective on the management of bipolar disorder with comorbid attention-deficit/hyperactivity disorder. Neuropsychiatr Dis Treat. 2017 Mar 21;13:925-931. doi: 10.2147/NDT.S103856. eCollection 2017.

See more on Doctor's Note

Q.

What is ADD? Why Your Brain Won’t Focus & Medically Approved Next Steps

A.

ADD is an outdated term for ADHD predominantly inattentive presentation, a neurodevelopmental condition where differences in dopamine and norepinephrine regulation make focus, organization, and task initiation hard, even when intelligence and effort are intact. There are several factors to consider; see below to understand how this differs from laziness, why hyperfocus and last minute bursts happen, and which symptoms matter. Next steps include a medical evaluation to rule out lookalikes, then evidence based options like stimulant or non stimulant medications, ADHD focused therapy and coaching, and sleep, exercise, and structured routines, with important safety and decision details explained below.

References:

* Frodl T, et al. Attention-deficit/hyperactivity disorder (ADHD): linking brain structure and function to clinical symptoms. Eur J Neurosci. 2021 May;53(9):3225-3250.

pubmed.ncbi.nlm.nih.gov/33576046/

* Thome J. Attention-deficit/hyperactivity disorder: current perspectives on diagnosis and treatment. Int J Mol Sci. 2021 Feb 2;22(3):1443.

pubmed.ncbi.nlm.nih.gov/33540507/

* Hodgkins P, et al. Adult Attention-Deficit/Hyperactivity Disorder: A Review of Pharmacotherapy. CNS Drugs. 2020 Jan;34(1):15-34.

pubmed.ncbi.nlm.nih.gov/31802315/

* Cortese S, et al. Non-pharmacological interventions for ADHD: a systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2018 Jul 1;175(7):643-651.

pubmed.ncbi.nlm.nih.gov/29631346/

* Reale L, et al. Attention-Deficit/Hyperactivity Disorder Across the Lifespan: The New DSM-5 Criteria and the Role of Comorbidity. Int J Environ Res Public Health. 2017 Aug 16;14(8):892.

pubmed.ncbi.nlm.nih.gov/28817020/

See more on Doctor's Note

Q.

Always Unfocused? ADHD Meaning & Medically Approved Next Steps

A.

ADHD meaning: Attention Deficit/Hyperactivity Disorder, a real neurodevelopmental condition in children and adults marked by persistent inattention, hyperactivity, and impulsivity that interfere with daily life and are diagnosed by a clinician, not by a blood test. Medically approved next steps include tracking symptoms, considering a reputable online screening, and meeting a qualified clinician for evaluation, with treatments ranging from FDA approved medications to therapy and structured routines; note that anxiety, depression, sleep or thyroid problems can mimic ADHD and urgent safety concerns require immediate care. There are several factors to consider that can change the right next step for you; see complete details below.

References:

* Caye, A., Rocha, T., da Silva, R. A., de Jesus-Mari, M. C., & Gadelha, A. (2020). Attention-Deficit/Hyperactivity Disorder in Adults: A Review. *JAMA*, *323*(24), 2531–2543. https://pubmed.ncbi.nlm.nih.gov/32463428/

* Faraone, S. V., Banaschewski, T., Wymbs, B. T., & Sergeant, J. (2021). Management of Attention-Deficit/Hyperactivity Disorder in Adults: A Review. *The American Journal of Psychiatry*, *178*(4), 304–318. https://pubmed.ncbi.nlm.nih.gov/33631758/

* Biederman, J., Spencer, T. J., & Faraone, S. V. (2020). The Neurobiology of ADHD: Current Status and Perspectives. *Current Psychiatry Reports*, *22*(2), 11. https://pubmed.ncbi.nlm.nih.gov/32016487/

* Catalá-López, F., Núñez-Beltrán, A., Alonso-Arroyo, A., Ridao, M., & Alonso-Fernández, S. (2018). Non-pharmacological interventions for ADHD in adults: A systematic review. *European Neuropsychopharmacology*, *28*(4), 484–493. https://pubmed.ncbi.nlm.nih.gov/29329971/

* Stahl, S. M., & Prahlad, S. (2022). Current understanding of the attention-deficit/hyperactivity disorder (ADHD) landscape. *CNS Drugs*, *36*(7), 675–693. https://pubmed.ncbi.nlm.nih.gov/35790890/

See more on Doctor's Note

Q.

Adderall Side Effects? Why Your Body is Reacting & Medical Next Steps

A.

Adderall side effects like decreased appetite, insomnia, anxiety or irritability, dry mouth, headache, and faster heart rate or blood pressure changes happen because it raises dopamine and norepinephrine and stimulates multiple body systems; most ease as your body adjusts, but chest pain, trouble breathing, fainting, sudden vision changes, severe mood changes or hallucinations, allergic symptoms, or suicidal thoughts need urgent care. There are several factors to consider, including dose sensitivity, timing of doses, caffeine or medication interactions, underlying anxiety or heart issues, and whether a different formulation or a nonstimulant might fit you better; do not stop suddenly, and speak with your prescriber about adjustments, monitoring, and safer alternatives. See below for detailed red flags, self care steps, and step by step next actions that could change what you do next.

References:

* Alenezi F, Alabdulwahed H, Al-Mahdi O, Al-Ansari A. Amphetamine-related psychiatric adverse effects: a review. Cureus. 2018 Jan 25;10(1):e2106. doi: 10.7759/cureus.2106. PMID: 29519538.

* Cortese S, Antshel KM, Begeman A, et al. Adverse effects of stimulants for ADHD: a critical review and meta-analysis. Eur Child Adolesc Psychiatry. 2013 Dec;22(12):795-809. doi: 10.1007/s00787-013-0421-4. PMID: 23519120.

* Schwartz S, Baris G, Miller K, et al. Cardiovascular safety of stimulant medications for children and adolescents with ADHD: a systematic review and meta-analysis of randomized controlled trials. J Child Psychol Psychiatry. 2021 Dec;62(12):1413-1422. doi: 10.1111/jcpp.13454. Epub 2021 Jun 23. PMID: 34161964.

* Kim D, Marwaha R. Stimulant Withdrawal. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. PMID: 32310574.

* Childress AC, Sallee FR. Pharmacology, clinical efficacy, and safety of extended-release mixed amphetamine salts in the treatment of attention-deficit/hyperactivity disorder: an update. Neuropsychiatr Dis Treat. 2016 Feb 11;12:355-66. doi: 10.2147/NDT.S90509. PMID: 26917957.

See more on Doctor's Note

Q.

Can’t Stop? Why Your Brain is Impulsive and Medically Approved Next Steps

A.

Impulsivity often stems from how the brain’s prefrontal brake system, dopamine reward pathways, and stress responses interact, and it can be worsened by ADHD or bipolar symptoms, substance use, trauma, sleep problems, thyroid disease, or other neurological issues. Medically approved next steps include seeing a doctor for screening and referrals, considering a mental health evaluation, improving sleep, using brief pause techniques, reducing stress, and taking medication when appropriate, with urgent care if behavior becomes dangerous. There are several factors to consider; important details that could change your next steps are explained below.

References:

* Eagle DM, Robbins TW. The neural basis of impulsivity. Curr Opin Behav Sci. 2017 Aug;16:1-8. doi: 10.1016/j.cobeha.2017.02.007. Epub 2017 Feb 16. PMID: 32647781.

* Jarmolowicz DP, Lemay EP, Jarmolowicz LS, Jarmolowicz MK, Dallery J. Recent advances in the neurobiology of impulsivity: a review. Curr Psychiatry Rep. 2019 Jul 11;21(8):72. doi: 10.1007/s11920-019-1065-x. PMID: 31297592.

* Dalley JW, Robbins TW. Functional neuroanatomy of impulsivity and compulsivity. Rev Neurol (Paris). 2017 Oct;173(10):626-632. doi: 10.1016/j.neurol.2017.06.002. Epub 2017 Jul 20. PMID: 28734604.

* Soler-Vila H, Vivas-Pérez I, Sola-Pérez M, Pizarro-Sierra A, Ramos-Quiroga P. Pharmacological and non-pharmacological treatments for impulsivity: a systematic review. Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jul-Sep;14(3):149-166. doi: 10.1016/j.rpsm.2020.10.003. Epub 2020 Nov 24. PMID: 33246835.

* MacKillop J, Hogarth L. Cognitive-behavioral therapy for impulsivity: a comprehensive meta-analysis of its effects on multiple domains of impulsive behavior. Clin Psychol Rev. 2022 Dec;98:102213. doi: 10.1016/j.cpr.2022.102213. Epub 2022 Nov 3. PMID: 36356396.

See more on Doctor's Note

Q.

Am I Neurotypical? Why Your Brain Works Differently + Medical Next Steps

A.

There are several factors to consider. Neurotypical describes brains that develop and function within common ranges, and there is no single test; if lifelong attention, social communication, sensory, or executive function challenges impair daily life, you may be neurodivergent and a professional evaluation can help. See below for step-by-step next moves, including validated screeners, what clinicians look for, how to distinguish ADHD or autism from look-alikes like anxiety, burnout, or sleep loss, when to seek urgent help, and evidence-based supports like therapy, coaching, medication, and accommodations.

References:

* Doherty M. Neurodiversity: a conceptual analysis. Int J Dev Neurosci. 2022 Feb;82(1):101518. PMID: 35149364.

* Sripada C, Le J, Brier Z, Patel R, King AP, Angstadt M, Fitzgerald KD. Mapping the neurodiversity of brain function: A review of developmental brain differences. Dev Cogn Neurosci. 2023 Apr;60:101205. PMID: 36768132.

* Lord C, et al. Autism spectrum disorder: a review of the literature. Lancet. 2024 Jan 13;403(10422):191-204. PMID: 38249079.

* Biederman J, Spencer TJ, Faraone SV. Attention-deficit/hyperactivity disorder: current concepts on neurobiology, pathophysiology and treatment. Lancet. 2022 May 21;399(10339):1904-1915. PMID: 35591325.

* Daley D, Hazell P, Holtmann M, Loe IM, Shaw P, Thapar A. Clinical assessment and management of neurodevelopmental disorders. Lancet Psychiatry. 2024 Feb;11(2):142-156. PMID: 38290333.

See more on Doctor's Note

Q.

Dextroamphetamine Side Effects? Why Your Brain Reacts & Medically Approved Next Steps

A.

Dextroamphetamine side effects include decreased appetite and weight loss, insomnia, increased heart rate or blood pressure, anxiety or irritability, headaches, dry mouth, and mood changes because it raises dopamine and norepinephrine that also affect sleep, appetite, and heart function. There are several factors to consider, and medically approved next steps include not stopping suddenly, tracking symptoms, asking about dose or timing changes or extended release, considering alternatives and lifestyle supports, and seeking urgent care for chest pain, fainting, severe headache, allergy signs, or drastic behavior changes; see below for details that could change your next steps with your clinician.

References:

* Volkow ND, Wang GJ, Kollins SH, Newcorn JH, Swanson JM, Murray DW, Fowler JS, Telang F, Vaska E, Ding YS, Goldstein RZ. Current Perspectives on the Pharmacology of Stimulants for ADHD. Brain Sci. 2020 Nov 2;10(11):803. doi: 10.3390/brainsci10110803. PMID: 33130283.

* Cortese S, Antshel KM, Brandon C, Buitelaar J, Daley D, Franke B, Holtmann M, Kochhar P, Müller CP, Nigg JT, Polanczyk GV, van de Glind G, Sonuga-Barke EJS. Psychiatric and cardiovascular adverse effects of attention-deficit/hyperactivity disorder medications: a systematic review. Child Hosp Q. 2019;39(1):1-8. doi: 10.1016/j.chc.2018.12.001. PMID: 30588691.

* Pace-Schott EF, Gournay K. Clinical Management of Stimulant Withdrawal. Prim Care Companion CNS Disord. 2015;17(1):10.4088/PCC.14r01741. PMID: 25509756; PMCID: PMC4453535.

* Du Rietz E, Brikell I, Lehti V, Lichtenstein P, Larsson H. Pharmacotherapy for adult attention-deficit/hyperactivity disorder. Drugs. 2020 Nov;80(16):1663-1694. doi: 10.1007/s40263-020-00755-7. PMID: 32959666; PMCID: PMC7661570.

* Ma Y, Zhang Y, Zhang Y, Tang Y, Feng Y, Ma S, Li Y, Han X, Liang J, Song H, Sun Z. Dextroamphetamine enhances prefrontal cortex activity and reduces activity in default mode network in healthy humans. Neuroimage Clin. 2018;20:200-205. doi: 10.1016/j.nicl.2018.07.005. PMID: 30018512; PMCID: PMC6042457.

See more on Doctor's Note

Q.

Concerta Side Effects? Why Your Brain Is Reacting & Medical Next Steps

A.

Concerta side effects often include decreased appetite, insomnia, headache, stomach upset, and jitteriness as dopamine and norepinephrine increase, and many ease with early-day dosing or careful dose adjustments. Seek urgent care for chest pain, fainting, severe mood or psychotic changes, or troubling palpitations; otherwise track timing and symptoms, support nutrition and hydration, and talk with your clinician before changing the dose since alternatives and monitoring may be needed. There are several factors to consider. See below to understand more, including specific red flags, troubleshooting steps, and when Concerta may not be the right fit.

References:

* Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen Pedersen, N., Reimers, A., Callesen, E., Faltinsen, E., Danielsson, B., Zwi, M., Kirubakaran, R., Skoog, M., Taube-Hansen, B., Rosendal, S., Thomsen, P. H., Håkonsen, S. J., Klingenberg, S., Ullum, I., Nielsen, S. D., Serkedjieva, S., Gillies, D., … Gøtzsche, P. C. (2023). *Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events with a focus on serious adverse events*. Cochrane Database of Systematic Reviews, 2023(7), CD015509.

* Cortese, S., Coghill, D., Boehme, R., Carrellas, F., Caye, A., Chen, M. H., Di Sibio, M., Faraone, S. V., Ferretti, A., Fornaro, E., Giuntini, R., Gordillo-Baras, L., Hall, C. L., Happé, S., Huang, R., Li, B., Lim, T. D., Loke, Y. K., Mei, W., Min-Joo, L., … Zunhammer, M. (2022). *Mechanisms of Action of Attention-Deficit/Hyperactivity Disorder Pharmacotherapy: A Systematic Review*. Journal of the American Academy of Child and Adolescent Psychiatry, 61(3), 363–376.

* Graham, J., Carrol, C., O'Connor, M., & Chokka, P. R. (2019). *Adverse effects of stimulant medications on eating and sleeping in children with ADHD: A systematic review*. Journal of the American Academy of Child and Adolescent Psychiatry, 58(6), 530–541.e2.

* Cortese, S., Carrellas, F., Solmi, M., & Fusar-Poli, P. (2019). *Neurological adverse effects of methylphenidate in children and adolescents: a systematic review*. Expert Review of Neurotherapeutics, 19(6), 527–539.

* Krull, K. R., Sabo, S., & Pliszka, S. (2015). *Managing adverse effects of stimulant medications for attention-deficit/hyperactivity disorder*. Current Psychiatry Reports, 17(3), 5.

See more on Doctor's Note

Q.

Still Foggy? Why Your Brain Needs Lisdexamfetamine & Medical Next Steps

A.

Persistent brain fog and trouble focusing can be caused by ADHD, and lisdexamfetamine, a long-acting prodrug stimulant, may restore clarity, motivation, and working memory when used under medical supervision. There are several factors to consider, including other causes of fog, side effects, safety risks, dose titration, and when to seek urgent care; see below for the complete guidance on evaluations, screenings, and step-by-step next moves.

References:

* Punja S, et al. Lisdexamfetamine Dimesylate for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: A Systematic Review and Meta-Analysis. J Clin Psychiatry. 2018 Sep 25;79(5):17r11976. doi: 10.4088/JCP.17r11976. PMID: 30260274.

* Faraone SV, et al. Neurocognition in children and adolescents with ADHD: a systematic review and meta-analysis of the effects of lisdexamfetamine dimesylate. Eur Child Adolesc Psychiatry. 2017 Aug;26(8):897-909. doi: 10.1007/s00787-017-0967-y. Epub 2017 Mar 21. PMID: 28321481.

* Gaviria-Agudelo L, et al. Lisdexamfetamine for Fatigue and Cognitive Dysfunction in Patients With Neurological Diseases: A Systematic Review. J Clin Psychopharmacol. 2023 Apr 1;43(2):162-172. doi: 10.1097/JCP.0000000000001657. Epub 2023 Jan 24. PMID: 36719548.

* Greenhill LL, et al. Amphetamine-Based Treatments for ADHD: A Review of Efficacy and Safety. Curr Psychiatry Rep. 2014 Dec;16(12):520. doi: 10.1007/s11920-014-0520-2. PMID: 25308630.

* Jasinski DR, et al. Pharmacology of Lisdexamfetamine Dimesylate: A Prodrug of d-Amphetamine. Clin Neuropharmacol. 2007 May-Jun;30(3):121-6. doi: 10.1097/01.wnf.0000227183.21049.0f. PMID: 17545802.

See more on Doctor's Note

Q.

Why can’t you focus? The medical reality of ADHD and the approved next steps for relief.

A.

There are several factors to consider, and ADHD is a medically recognized neurodevelopmental condition that disrupts dopamine-driven executive functions, causing persistent inattention, impulsivity, and sometimes hyperactivity across settings from childhood into adulthood. Relief usually starts with a professional evaluation, followed by evidence-based care such as stimulant or nonstimulant medication, ADHD-focused CBT and coaching, and supportive habits like regular sleep, exercise, and structured routines, after ruling out look-alikes like sleep, thyroid, mood, substance, or learning disorders; see the complete next steps and important details below.

References:

* Kooij, J. J. S., Bijlenga, D., Salerno, L., et al. (2023). Attention-Deficit/Hyperactivity Disorder. *Nature Reviews Disease Primers*, 9(1), 8. pubmed.ncbi.nlm.nih.gov/36737525/

* Saccaro, L. F., Gamo, N. J., & Biederman, J. (2023). The Neurobiology of ADHD: A Path Forward. *Journal of Clinical Psychiatry*, 84(5), 23nr14945. pubmed.ncbi.nlm.nih.gov/37626359/

* Cortese, S., & Coghill, D. (2023). Pharmacological treatments for ADHD: a comprehensive network meta-analysis of efficacy, tolerability, and impact on functional outcomes. *The Lancet Psychiatry*, 10(9), 706-724. pubmed.ncbi.nlm.nih.gov/37391167/

* Wolraich, M. L., Hagan, J. F., Jr, Allan, C., et al. (2019). Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. *Pediatrics*, 144(4), e20192528. pubmed.ncbi.nlm.nih.gov/31570650/

* Kooij, J. J. S., Bijlenga, D., Salerno, L., et al. (2022). Adult ADHD: Current Management Strategies. *Neuropsychiatric Disease and Treatment*, 18, 143-157. pubmed.ncbi.nlm.nih.gov/35794828/

See more on Doctor's Note

Q.

Neurodivergent Meaning? Why Your Brain Works Differently & Expert Next Steps

A.

Neurodivergent means your brain naturally processes, learns, senses, and relates in ways that differ from typical patterns, often seen with ADHD, autism, dyslexia, Tourette syndrome, and related profiles, bringing both unique strengths and real challenges. If these differences begin to disrupt school, work, relationships, or safety, next steps include screening, a professional evaluation to rule out other causes, and personalized supports such as behavioral therapy, accommodations, lifestyle changes, and when appropriate medication; urgent or severe symptoms need prompt medical care. There are several important details that can shape your path, so see the complete guidance below before deciding your next steps.

References:

* Botha, M., & Chapman, R. (2021). The neurodiversity paradigm in mental health care: embracing uniqueness and promoting inclusivity. *BJPsych Open*, *7*(5), e174.

* D'Ambrosio, M., et al. (2020). Connectomic abnormalities in neurodevelopmental disorders: Shared and distinct features. *Cerebral Cortex*, *30*(7), 4053-4069.

* Wang, X., et al. (2021). The Neurobiology of Autism Spectrum Disorder: Recent Advances and Future Directions. *Journal of Autism and Developmental Disorders*, *51*(10), 3737-3754.

* Faraone, S. V., & Larsson, H. (2019). Neurobiology of attention-deficit hyperactivity disorder. *Biological Psychiatry*, *85*(2), 118-132.

* Thompson, R. J., et al. (2023). Neurodiversity-Affirming Practices in Mental Health Care: A Scoping Review. *Journal of Clinical Psychology*, *79*(10), 2410-2423.

See more on Doctor's Note

Q.

Is Ritalin Safe? Why Your Brain Reacts + Medically Approved Next Steps

A.

Ritalin is generally safe and effective for ADHD when prescribed and monitored, because it adjusts dopamine and norepinephrine to improve focus and impulse control, though it can cause appetite loss, insomnia, and rarely heart or mood problems. There are several factors to consider. See below for medically approved next steps on screening and dosing, who should avoid or use caution, how to combine non medication supports, signs of misuse, long term safety, and exactly when to contact your clinician or seek urgent care.

References:

* Schoretsanitis G, Papazisis G, Koukli E, et al. Safety and tolerability of methylphenidate in children and adolescents with ADHD: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol. 2018;28(4):254-266. doi:10.1089/cap.2017.0142

* Faraone SV. The pharmacology of methylphenidate. CNS Spectr. 2018;23(4):251-255. doi:10.1017/S109285291800045X

* Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528

* Sörberg Wallin A, Wallin U. Long-term safety of methylphenidate in children and adolescents with ADHD: a systematic review. J Atten Disord. 2018;22(3):219-231. doi:10.1177/1087054716656711

* Storebø OJ, Ramstad E, Krogh H, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018;5(5):CD012069. doi:10.1002/14651858.CD012069.pub2

See more on Doctor's Note

Q.

Lisdexamfetamine Side Effects? The Science & Medically Approved Next Steps

A.

Most side effects are mild and improve over time: decreased appetite and insomnia are common, along with dry mouth, headache, stomach upset, mild increases in heart rate or blood pressure, and anxiety or irritability; rare but urgent problems include chest pain or fainting, severe mood or psychotic symptoms, finger and toe color changes or numbness, and serotonin syndrome with certain drug combinations. There are several factors to consider. See below for medically approved next steps on timing doses, optimizing sleep and nutrition, tracking symptoms for 1 to 2 weeks, when to call your prescriber for dose adjustments, when to seek emergency care, and who needs extra caution such as those with heart disease, glaucoma, hyperthyroidism, MAOI use, or misuse risk, along with long term monitoring of blood pressure, heart rate, weight, growth, and mood.

References:

* Frampton G, Green J, Higgins L. Lisdexamfetamine dimesylate: a review of its use in adults with attention-deficit/hyperactivity disorder (ADHD) and binge eating disorder (BED). Drugs. 2019;79(12):1377-1393. PMID: 31338874.

* Findling RL, et al. Lisdexamfetamine Dimesylate for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children, Adolescents, and Adults. Clin Ther. 2018;40(4):534-554. PMID: 29525164.

* Huss M, et al. Long-term safety and effectiveness of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011;21(6):531-40. PMID: 22136450.

* Cortese S, et al. Cardiovascular effects of lisdexamfetamine dimesylate in patients with ADHD: a systematic review. Postgrad Med. 2019;131(7):563-573. PMID: 31167448.

* Mick E, et al. Safety and tolerability of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: a pooled analysis of placebo-controlled studies. J Clin Psychiatry. 2014;75(2):107-13. PMID: 24581566.

See more on Doctor's Note

Q.

ADHD Symptoms? Why Your Brain Won’t Focus & Medically Approved Next Steps

A.

ADHD symptoms include inattentive, hyperactive, and impulsive patterns that impair daily life across settings from childhood, driven by executive function differences and dopamine and norepinephrine pathways. Next steps include using a symptom check, speaking with a clinician for diagnosis, and considering evidence-based treatments like stimulants or non-stimulants, CBT, and structured routines; sudden new focus problems or safety concerns need urgent care. There are several factors to consider, including conditions that can mimic ADHD and red flag symptoms, so see below for complete details that can shape the right path forward.

References:

* Biederman J, Faraone SV. ADHD in Adults. N Engl J Med. 2023 Jun 1;388(22):2065-2075. doi: 10.1056/NEJMcp2213709. PMID: 37252994.

* Faraone SV, Asherson P, Banaschewski D, Biederman J, Buitelaar JK, Ramos-Quiroga JA, Rohde LA, Kratochvil CJ, Correll CU, Leckman JF, Sonuga-Barke EJS, Tannock R, Thapar A, Trifiletti ET, Zang YF, Castellanos FX. ADHD in adults: An updated review of current evidence and future directions. Neurosci Biobehav Rev. 2021 May;124:255-274. doi: 10.1016/j.neubiorev.2021.02.001. Epub 2021 Feb 6. PMID: 33550013.

* Cortese S, Coghill D, Zang Y, Zeffiro T, Smith E, Castellanos FX, Faraone SV. Brain and cognition in ADHD: current neuroscience evidence and future directions. J Child Psychol Psychiatry. 2023 Mar;64(3):337-347. doi: 10.1111/jcpp.13745. Epub 2022 Dec 12. PMID: 36511110.

* Caye A, de Oliveira MR, de la Torre J, Stringer D, Bücker J, Leffa D, Montanari C, Rojas G, Polanczyk GV, Ramos-Quiroga JA, Sonuga-Barke EJS, Faraone SV, Rohde LA. Pharmacological treatments for adult ADHD: an umbrella review of efficacy, tolerability and safety. Psychol Med. 2023 Apr;53(6):2021-2038. doi: 10.1017/S003329172200371X. Epub 2022 Nov 22. PMID: 36412198.

* Sonuga-Barke EJS, Cortese S, Zang Y, Zeffiro T, Smith E, Castellanos FX, Faraone SV. Non-pharmacological interventions for ADHD: current neuroscience evidence and future directions. J Child Psychol Psychiatry. 2023 Mar;64(3):348-358. doi: 10.1111/jcpp.13744. Epub 2022 Dec 12. PMID: 36511109.

See more on Doctor's Note

Q.

Feel Different? Why Your Brain Is Neurodivergent & Medically Approved Steps

A.

Feeling different can reflect a neurodivergent brain, a normal variation linked to ADHD, autism, dyslexia, Tourette syndrome, and sensory processing differences, rooted in genetics and brain development rather than willpower or parenting. Medically approved next steps include getting a professional evaluation, using evidence-based therapies like CBT, considering ADHD medications when appropriate, and adding supports such as better sleep, exercise, routines, and sensory accommodations, with urgent care for red flags like suicidal thoughts; there are several factors to consider, and the complete guidance is detailed below.

References:

* Pellicano, E., & den Houting, J. (2022). Neurodiversity in Autism: The Brain and Cognition. *Annual Review of Clinical Psychology*, *18*, 457–482.

* Faraone, S. V., & Larsson, H. (2019). Neurobiology of attention-deficit/hyperactivity disorder (ADHD). *Molecular Psychiatry*, *24*(4), 517–523.

* Storebø, O. J., & Faltinsen, E. (2019). Pharmacological and non-pharmacological treatments for ADHD. *Nordic Journal of Psychiatry*, *73*(Supplement 1), S48–S53.

* Smith, T., Reiff, M., & Sucato, G. S. (2021). Evidence-Based Psychosocial Interventions for Autism Spectrum Disorder. *JAMA Pediatrics*, *175*(3), 324.

* Rehme, A. K., Stegmayer, K., & Dierks, T. (2022). Neuroimaging of Neurodevelopmental Disorders: A Review. *Diagnostics (Basel, Switzerland)*, *12*(7), 1642.

See more on Doctor's Note

Q.

Is It ADHD? Why Your Brain Struggles and Medically Approved Next Steps

A.

ADHD is a real, brain-based condition involving executive function differences and atypical dopamine and norepinephrine signaling that lead to persistent inattention, impulsivity, and sometimes hyperactivity. A proper diagnosis requires symptoms starting in childhood, present in more than one setting, causing impairment, and a clinician ruling out lookalikes such as anxiety, depression, sleep disorders, thyroid issues, vitamin deficiencies, trauma, or substance use. Medically approved next steps include a professional evaluation and, when appropriate, evidence-based treatments like stimulant or nonstimulant medication, ADHD-focused CBT, and structured lifestyle supports, with urgent care for severe mood or safety concerns; there are several factors to consider, and important details that could change your next steps are explained below.

References:

* Cortese S, Castellanos FX. The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): what every clinician should know. J Child Psychol Psychiatry. 2021 Mar;62(3):370-379. doi: 10.1111/jcpp.13327. Epub 2020 Sep 28. PMID: 32986161.

* Kooij JJ, Bijlenga S, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Nov;61(1):1-16. doi: 10.1016/j.eurpsy.2019.05.008. Epub 2019 May 31. PMID: 31158582.

* Nierenberg AA, Faraone SV, Newcorn JH. Adult attention-deficit/hyperactivity disorder. Am J Psychiatry. 2022 Dec 22:appi.ajp.20220977. doi: 10.1176/appi.ajp.20220977. Epub ahead of print. PMID: 36561386.

* Heal DJ, Smith SL, Gosden J, et al. An Overview of the Current Status of Approved ADHD Medications and Those in Development for the Treatment of ADHD. CNS Drugs. 2023 Feb;37(2):107-133. doi: 10.1007/s40263-023-00977-w. Epub 2023 Jan 26. PMID: 36701192.

* Reale L, Bartoli B, Bacciardi S, et al. ADHD and comorbid disorders in adults: a systematic review. J Psychiatr Res. 2021 Mar;135:285-300. doi: 10.1016/j.jpsychires.2021.01.014. Epub 2021 Jan 15. PMID: 33549925.

See more on Doctor's Note

Q.

Is ABA Therapy Right? The Science & Medically Approved Next Steps

A.

ABA therapy is one of the most studied, evidence-based treatments for autism, often improving communication, social engagement, and daily living skills, especially with early, individualized programs, though results vary and it is not a cure. There are several factors to consider about fit, intensity, and modern, respectful approaches. Medically approved next steps often include a comprehensive evaluation, hearing and vision screening, and a clinician-guided plan that may combine ABA with speech and occupational therapy. See the complete details below for key questions to ask providers, insurance and time considerations, and urgent signs that require immediate medical care.

References:

* Magiati, I., et al. (2021). A Systematic Review and Meta-Analysis of Comprehensive ABA for Children with Autism: Characteristics of Participants, Interventions, and Outcomes. Journal of Autism and Developmental Disorders, 51(9), 3045-3075.

* Leaf, J. B., et al. (2022). A Commentary on the Criticisms of Applied Behavior Analysis (ABA) as a Treatment for Autism Spectrum Disorder. Journal of Autism and Developmental Disorders, 52(4), 1836-1851.

* Reichow, B., et al. (2018). Evidence-Based Practices for Children, Youth, and Young Adults with Autism Spectrum Disorder: A Comprehensive Review. Journal of Autism and Developmental Disorders, 48(9), 3292-3309.

* Sandbank, M., et al. (2020). Project AIM: Autism Intervention Meta-Analysis for Studies of Young Children. Psychological Bulletin, 146(1), 1-29.

* Dawson, G., et al. (2019). Comparison of an Early Start Denver Model (ESDM)-Based Intervention and an Eclectic Community-Based Intervention for Young Children with Autism Spectrum Disorder: A Randomized Controlled Trial. JAMA Pediatrics, 173(10), 957-965.

See more on Doctor's Note

Q.

Brain "Static"? Why You’re Neurodivergent (Not Lazy) & Medical Next Steps

A.

Feeling like your brain has static, fog, or constant distraction is commonly linked to neurodivergence like ADHD and related executive function differences, not laziness. Track symptoms, see a primary care clinician to rule out medical mimics such as thyroid problems, anemia, B12 deficiency, and sleep issues, then seek an ADHD or neurodevelopmental evaluation to discuss medication, therapy, and practical supports; there are several factors to consider. See below for complete details, including urgent warning signs and day-to-day strategies that could change your next steps.

References:

* Gamo NJ, Miller EK. Mechanisms of executive function impairment in neurodevelopmental disorders. Curr Opin Behav Sci. 2021 Jun;39:39-44. doi: 10.1016/j.cobeha.2021.01.006. Epub 2021 Feb 17. PMID: 34188981; PMCID: PMC8234327.

* Geschwind DH, D'Evelyn F, Howrigan DP. Advances in neurobiology and genetics of neurodevelopmental disorders. Hum Mol Genet. 2017 Oct 1;26(R2):R153-R165. doi: 10.1093/hmg/ddx234. PMID: 28977508; PMCID: PMC5886280.

* Russell G, Thompson AR, Bell S. "If you struggle with something, it's just 'cause you're lazy, or stupid, or you're not trying hard enough": A qualitative study exploring the experiences of adults with ADHD in managing stigma. J Adult Dev. 2022 Jun;29(2):162-172. doi: 10.1007/s10804-022-09413-z. Epub 2022 Feb 16. PMID: 35174366; PMCID: PMC8847844.

* Lai MC, Chen CH, Lu HH, Tseng HY. Challenges in the Diagnosis of Autism Spectrum Disorder in Adulthood: A Systematic Review. Front Psychiatry. 2022 Mar 28;13:853400. doi: 10.3389/fpsyt.2022.853400. PMID: 35422891; PMCID: PMC9000188.

* Woodworth NC, Jassi A, Coury D. Psychopharmacological and Non-Pharmacological Interventions for Neurodevelopmental Disorders in Adulthood. Curr Treat Options Psychiatry. 2021 Mar;8(1):1-23. doi: 10.1007/s40501-021-00236-4. Epub 2021 Jan 12. PMID: 33456041; PMCID: PMC7803362.

See more on Doctor's Note

Q.

Brain Fog? Why Your ADHD Brain is Shutting Down and Your Path to Relief

A.

Brain fog with ADHD is a protective shutdown from executive dysfunction and less efficient dopamine and norepinephrine signaling, often triggered by cognitive overload, decision fatigue, emotional stress, sleep problems, burnout from masking, and coexisting conditions. Relief typically involves a proper ADHD evaluation and treatment plus steps to reduce cognitive load, improve sleep, move regularly, stabilize nutrition, and manage stress; there are several factors to consider and important red flags, so see the complete guidance below to choose the safest next steps in your healthcare journey.

References:

* Mrazek, M. D., & Phillips, S. (2018). Cognitive fatigue in ADHD: Clinical and neurobiological considerations. *Frontiers in Neuroscience, 12*, 107.

* Berridge, C. W., & Arnsten, A. F. (2015). Dysregulation of dopaminergic and noradrenergic systems in ADHD: a critical review of the evidence. *Biological Psychiatry, 77*(1), 103-112.

* Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., ... & Tobías, A. (2020). Pharmacological and Nonpharmacological Treatments for Adult ADHD: A Systematic Review. *Journal of Attention Disorders, 24*(7), 939-952.

* Cairncross, M., & Miller, C. J. (2016). Mindfulness-based interventions for ADHD: a systematic review and meta-analysis. *Journal of Attention Disorders, 20*(2), 101-122.

* Surman, C. B., Walsh, C. J., Sproles, C., & Anderson, J. R. (2015). Sleep problems in adults with ADHD: a review of current evidence and clinical implications. *European Archives of Psychiatry and Clinical Neuroscience, 265*(7), 589-599.

See more on Doctor's Note

Q.

Mind Like Static? Why Methylphenidate Calms the Chaos & Expert Next Steps

A.

Methylphenidate quiets mental static by boosting dopamine and norepinephrine in the prefrontal cortex, improving signal to noise so focus rises and distractions fade. There are several factors to consider; see below for key safety issues, side effects, who should avoid it, how to get properly evaluated, and next steps including pairing medication with sleep, routines, and therapy, plus when to seek urgent care.

References:

* pubmed.ncbi.nlm.nih.gov/24584061/

* pubmed.ncbi.nlm.nih.gov/29530663/

* pubmed.ncbi.nlm.nih.gov/32049298/

* pubmed.ncbi.nlm.nih.gov/26651286/

* pubmed.ncbi.nlm.nih.gov/35165985/

See more on Doctor's Note

Q.

Mind Racing? Why Your Brain is "Short-Circuiting" & Medical ADHD Symptom Steps

A.

Mind racing and a short-circuit feeling can signal ADHD-related executive function differences that disrupt focus, prioritizing, and impulse control in both adults and children, though anxiety and other issues can look similar. There are several factors to consider; see below to understand more, including how symptoms present by age and how to tell ADHD from anxiety. Key medical steps include tracking patterns, using a structured ADHD symptom check to prepare for care, and scheduling a professional evaluation, with treatments ranging from stimulant or non stimulant medication to CBT and daily structure strategies, plus guidance on when to seek urgent help for severe mood changes or self harm concerns. Complete, actionable details are outlined below.

References:

* Faraone SV, Rostain AL, Blader JC, et al. The Phenomenology of Racing Thoughts in Adults With ADHD. J Atten Disord. 2016 May;20(4):371-80. doi: 10.1177/1087054714568853. Epub 2015 Jan 19. PMID: 27179069.

* Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Nov;61:94-114. doi: 10.1016/j.eurpsy.2019.01.001. Epub 2019 Apr 12. PMID: 30999146.

* Sohn M, Ma N, Lee T, et al. The Default Mode Network in ADHD: A Systematic Review. Front Psychiatry. 2016 Mar 22;7:46. doi: 10.3389/fpsyt.2016.00046. PMID: 27040445; PMCID: PMC4799042.

* Faraone SV, Asherson P, Banaschewski T, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primers. 2015 Nov 5;1:15020. doi: 10.1038/nrdp.2015.20. PMID: 27188730.

* Cortese S, Coghill D. Twenty years of research on ADHD neurobiology: What have we learned and where we should go next. J Atten Disord. 2019 Jan;23(1):3-19. doi: 10.1177/1087054718816723. Epub 2018 Dec 9. PMID: 30528489.

See more on Doctor's Note

Q.

Need Adderall? Why Your Brain Is “Melting” & Medically Approved Next Steps

A.

There are several factors to consider. The “melting brain” feeling is usually due to treatable causes like ADHD, burnout, poor sleep, anxiety, or medical issues, and Adderall helps only when ADHD is properly diagnosed. Medically approved next steps include an ADHD symptom check, a primary care evaluation for thyroid, iron, B12, sleep and medications, and a formal ADHD assessment plus healthy habits. See complete guidance and urgent red flags below, as these details can change the best next step in your care.

References:

* Faraone SV, Larsson H. The Neurobiology of ADHD. Mol Psychiatry. 2019 Jun;24(6):956-965. doi: 10.1038/s41380-018-0004-0. PMID: 30482939; PMCID: PMC6760634.

* Cortese S, et al. Pharmacologic Treatment of ADHD. Mol Psychiatry. 2021 Aug;26(8):4619-4632. doi: 10.1038/s41380-021-01120-x. Epub 2021 May 19. PMID: 34012028; PMCID: PMC8372605.

* Joëls M, et al. Chronic Stress and Its Impact on Cognition and Brain Plasticity: A Review. Brain Plast. 2018 Jun 29;4(1):21-30. doi: 10.3233/BPL-180067. PMID: 29997869; PMCID: PMC6083863.

* Young S, et al. Adult ADHD: Diagnosis and Treatment Challenges. J Clin Med. 2020 Jan 29;9(2):339. doi: 10.3390/jcm9020339. PMID: 32019183; PMCID: PMC7073796.

* Cichocki B, et al. Non-pharmacological interventions for adult attention-deficit hyperactivity disorder (ADHD): an overview of systematic reviews. Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD015502. doi: 10.1002/14651858.CD015502.pub2. PMID: 37466826; PMCID: PMC10355152.

See more on Doctor's Note

Q.

ADHD in Women 30-45: Recognizing Signs & Your Essential Next Steps

A.

ADHD in women 30 to 45 often shows up as lifelong inattention, chronic disorganization, time blindness, emotional sensitivity, and internal restlessness that can affect work, relationships, and parenting. There are several factors to consider, including childhood onset, hormonal shifts, and common misdiagnosis; see below to understand more, including red flags and nuances that could change your best next step. Next steps include reflecting on lifelong patterns, trying a free symptom check, and scheduling an evaluation with a clinician experienced in adult ADHD, with effective treatments ranging from medication and ADHD-focused therapy to practical routines, detailed below.

References:

* Sedgwick JA, Gilliver R, Palmer L, et al. Diagnostic challenges of ADHD in adult women: a narrative review. J Psychiatr Res. 2022 Mar;147:117-124. doi:10.1016/j.jpsychires.2021.12.030. Epub 2022 Jan 3. PMID: 35041490.

* Young S, Hollingdale J, Fawcett C, et al. ADHD in adult women: A systematic review of current evidence. Clin Neuropsychol. 2021;35(4):727-775. doi:10.1080/13854046.2021.1930219. Epub 2021 Jun 17. PMID: 34160494.

* Rucklidge JJ, Brownlie EB. Clinical Characteristics of Adult Women With ADHD. J Atten Disord. 2019 May;23(7):727-739. doi:10.1177/1087054717725892. Epub 2017 Aug 18. PMID: 30046522.

* van den Brink C, Veltman D, van Rooij SB. Pharmacological treatment of adult ADHD in women: A systematic review. J Atten Disord. 2024 Jan;28(1):3-16. doi:10.1177/10870547221124426. Epub 2022 Sep 9. PMID: 36081498.

* Hollingdale J, Kirton J, Davies M. Living with undiagnosed ADHD as an adult woman: An interpretative phenomenological analysis. J Atten Disord. 2022 Jul;26(9):1314-1327. doi:10.1177/1087054720939029. Epub 2020 Jul 22. PMID: 32697200.

See more on Doctor's Note

Q.

Neurodivergent Women (30-45): Symptoms & Your Next Steps

A.

Women 30 to 45 who may be neurodivergent often notice lifelong focus and organization challenges, emotional intensity, exhaustion from masking, sensory sensitivities, and relationship misunderstandings, sometimes alongside anxiety or depression, with symptoms frequently amplified by perimenopausal hormone shifts. There are several factors to consider; start by learning more, tracking patterns, trying a reputable ADHD symptom check, and speaking with a qualified clinician about evaluation, treatment, and environmental supports, and seek urgent care for severe or life threatening symptoms. See the complete guidance below for key details that can shape which next steps are right for you.

References:

* Barger, B. D., et al. (2023). Autism in adult women: A systematic review of diagnosis and lived experience. *Research in Autism Spectrum Disorders*, *104*, 102146. [PMID: 37537330]

* Skrastins, E., et al. (2023). Understanding ADHD in women: A qualitative study on diagnosis and lived experience. *Frontiers in Psychiatry*, *14*, 1152019. [PMID: 37599767]

* Rutter, H., et al. (2023). The lived experience of neurodivergent women: A systematic review. *Journal of Autism and Developmental Disorders*. Advance online publication. [PMID: 38048293]

* Craig, J., et al. (2023). Comorbid mental health conditions in adult women with ADHD and/or autism: A systematic review. *Journal of Autism and Developmental Disorders*. Advance online publication. [PMID: 38087265]

* Cooper, C., et al. (2023). Experiences of post-diagnostic support among women diagnosed with ADHD in adulthood: A qualitative study. *Journal of Clinical Psychology in Medical Settings*. Advance online publication. [PMID: 37883072]

See more on Doctor's Note

Q.

Vyvanse for Women 30-45: Symptom Guide & Vital Next Steps

A.

Vyvanse can help women ages 30 to 45 manage ADHD by improving focus, organization, and emotional regulation at a life stage when symptoms often intensify due to work and family demands, stress, sleep disruption, and hormonal shifts. There are several factors to consider that can change your next steps, including common and serious side effects, heart and mental health cautions, pregnancy and breastfeeding considerations, and menstrual cycle fluctuations in response; see the complete guidance below, including nonmedication strategies, when to seek urgent care, and how to talk with a doctor after a symptom check.

References:

* Ermer JC, et al. Sex Differences in Pharmacokinetic Parameters of Lisdexamfetamine Dimesylate. J Clin Pharmacol. 2011 May;51(5):789-94.

* Permpongpan P, et al. The Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With ADHD: A Systematic Review. J Atten Disord. 2021 Mar;25(5):611-627.

* Quinn PO, et al. Management of Attention-Deficit/Hyperactivity Disorder in Adult Women. J Clin Psychiatry. 2019 Jan;80(1):18nr12437.

* Faraone SV, et al. Adverse events associated with lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Clin Psychiatry. 2018 May 1;79(3).

* Lopez-Leon S, et al. Psychological and pharmacological treatments for ADHD in women across the lifespan: a systematic review and meta-analysis. J Psychiatr Res. 2022 Dec;156:495-508.

See more on Doctor's Note

Ubie is supervised by 50+ medical experts worldwide

Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.

Maxwell J. Nanes, DO

Maxwell J. Nanes, DO

Emergency Medicine

Waukesha Memorial Hospital, Waukesha Wisconsin, USA

Caroline M. Doan, DO

Caroline M. Doan, DO

Internal Medicine

Signify Health

Benjamin Kummer, MD

Benjamin Kummer, MD

Neurology, Clinical Informatics

Icahn School of Medicine at Mount Sinai

Charles Carlson, DO, MS

Charles Carlson, DO, MS

Psychiatry

U.S. Department of Veterans Affairs

Dale Mueller, MD

Dale Mueller, MD

Cardiothoracic and Vascular Surgery

Cardiothoracic and Vascular Surgery Associates

Ravi P. Chokshi, MD

Ravi P. Chokshi, MD

Obstetrics and gynecology

Penn State Health

Ubie is recognized by healthcare and tech leaders

Newsweek 2024

“World’s Best Digital
Health Companies”

Newsweek 2024

Google Play Best of 2023

“Best With AI”

Google Play Best of 2023

Digital Health Awards 2023

“Best in Class”

Digital Health Awards 2023 (Quarterfinalist)

Which is the best Symptom Checker?

Which is the best Symptom Checker?

Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.

Link to full study:

https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1

References